Journal article icon

Journal article

Artemisinin resistance--modelling the potential human and economic costs

Abstract:

BACKGROUND: Artemisinin combination therapy is recommended as first-line treatment for falciparum malaria across the endemic world and is increasingly relied upon for treating vivax malaria where chloroquine is failing. Artemisinin resistance was first detected in western Cambodia in 2007, and is now confirmed in the Greater Mekong region, raising the spectre of a malaria resurgence that could undo a decade of progress in control, and threaten the feasibility of elimination. The magnitude of ...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1186/1475-2875-13-452

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDM, Tropical Medicine
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDM, Tropical Medicine
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDM, Tropical Medicine
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDM, Tropical Medicine
Expand authors...
Publisher:
BioMed Central Publisher's website
Journal:
Malaria journal Journal website
Volume:
13
Issue:
1
Pages:
452
Publication date:
2014-11-23
Acceptance date:
2014-11-14
DOI:
EISSN:
1475-2875
ISSN:
1475-2875
URN:
uuid:2fcad761-3c92-4a8d-af94-698379bf0897
Source identifiers:
491841
Local pid:
pubs:491841

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP